SG170823A1 - Test agent for diagnosing dyspepsia - Google Patents

Test agent for diagnosing dyspepsia

Info

Publication number
SG170823A1
SG170823A1 SG201102359-5A SG2011023595A SG170823A1 SG 170823 A1 SG170823 A1 SG 170823A1 SG 2011023595 A SG2011023595 A SG 2011023595A SG 170823 A1 SG170823 A1 SG 170823A1
Authority
SG
Singapore
Prior art keywords
measuring
gastric
present
dyspepsia
labeled
Prior art date
Application number
SG201102359-5A
Other languages
English (en)
Inventor
Makoto Inada
Jun-Ichi Kunizaki
Nobuhiro Ikei
Kuniaki Natsume
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SG170823A1 publication Critical patent/SG170823A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/497Physical analysis of biological material of gaseous biological material, e.g. breath
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/204998Inorganic carbon compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG201102359-5A 2006-04-13 2007-04-12 Test agent for diagnosing dyspepsia SG170823A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006111382 2006-04-13

Publications (1)

Publication Number Publication Date
SG170823A1 true SG170823A1 (en) 2011-05-30

Family

ID=38609531

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201102359-5A SG170823A1 (en) 2006-04-13 2007-04-12 Test agent for diagnosing dyspepsia

Country Status (10)

Country Link
US (1) US20100055799A1 (fr)
EP (1) EP2011518B1 (fr)
JP (1) JP5213702B2 (fr)
KR (2) KR101504571B1 (fr)
CN (1) CN101420985B (fr)
CA (1) CA2649262A1 (fr)
ES (1) ES2488412T3 (fr)
SG (1) SG170823A1 (fr)
TW (1) TWI409091B (fr)
WO (1) WO2007119771A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104737016B (zh) 2012-08-20 2017-09-29 大塚制药株式会社 测定糖代谢能力的方法及用于该方法的组合物
JP6305392B2 (ja) 2013-03-15 2018-04-04 大塚製薬株式会社 脂肪酸燃焼によるインスリン抵抗性の測定方法、並びにそれに使用する組成物
CN108030471B (zh) * 2017-12-20 2023-12-26 天津医科大学总医院 动物胃肠动力检测系统及检测方法
CN110743021A (zh) * 2019-11-29 2020-02-04 王相成 一种胃食管反流的液体试餐及其显像方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830010A (en) * 1986-04-04 1989-05-16 Marshall Barry J Methods for the diagnosis of gastrointestinal disorders
US5233997A (en) * 1991-04-04 1993-08-10 Baylor College Of Medicine Non-invasive measure of intestinal transit time and uses thereof
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
US5707602A (en) 1996-03-25 1998-01-13 Meretek Diagnostics Measurement of gastric emptying
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
WO1998006442A1 (fr) * 1996-08-13 1998-02-19 Kyowa Hakko Kogyo Co., Ltd. Comprimes a base d'uree isotopique
US6186958B1 (en) * 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
CA2250485C (fr) * 1997-10-21 2008-04-29 Tokyo Gas Co., Ltd. Agent de diagnostic du diabete
AU4802099A (en) * 1998-07-28 2000-02-21 Takeda Chemical Industries Ltd. Rapidly disintegrable solid preparation
US6740305B1 (en) * 1999-04-09 2004-05-25 Xanthus Life Scienes, Inc. Assessment of gastric emptying disorders
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
BR0110512A (pt) * 2000-05-02 2004-03-09 Otsuka Pharma Co Ltd Preparação para medir a taxa de esvaziamento gástrico
US7488466B2 (en) * 2001-03-13 2009-02-10 Otsuka Pharmaceutical Co., Ltd. Preparation for determining pyrimidine metabolic capacity
US6797256B2 (en) * 2001-03-13 2004-09-28 Otsuka Pharmaceutical Co. Ltd. Composition for determining pyrimidine metabolizing activity
JP5178195B2 (ja) * 2005-07-25 2013-04-10 大塚製薬株式会社 ピリジン代謝能の測定に有用な経口製剤

Also Published As

Publication number Publication date
CN101420985B (zh) 2011-11-09
JPWO2007119771A1 (ja) 2009-08-27
TW200744701A (en) 2007-12-16
CN101420985A (zh) 2009-04-29
EP2011518B1 (fr) 2014-06-18
EP2011518A1 (fr) 2009-01-07
EP2011518A4 (fr) 2011-04-20
WO2007119771A1 (fr) 2007-10-25
KR20140099331A (ko) 2014-08-11
US20100055799A1 (en) 2010-03-04
KR20080112328A (ko) 2008-12-24
KR101440980B1 (ko) 2014-09-17
TWI409091B (zh) 2013-09-21
CA2649262A1 (fr) 2007-10-25
KR101504571B1 (ko) 2015-03-20
JP5213702B2 (ja) 2013-06-19
ES2488412T3 (es) 2014-08-27

Similar Documents

Publication Publication Date Title
Dries et al. Inhalation injury: epidemiology, pathology, treatment strategies
WO2004063387A3 (fr) Nanoparticules fluorescentes a base de silice
WO2007019376A3 (fr) Methodes et compositions pour le diagnostic de maladies renales mediees par l'iga et l'igm
WO2006090389A3 (fr) Nouveaux marqueurs diagnostiques, en particulier pour l'imagerie in vivo, et dosage et procedes d'utilisation associes
EP2073706A4 (fr) Système d'analyse de perfusion tissulaire reposant sur l'utilisation d'une concentration de vert d'indocyanine dans le sang
AU2012262534A1 (en) Method of determining vasoreactivity using inhaled nitric oxide
WO2006042151A3 (fr) Analogues de la toxine shk et utilisations dans l'inhibition selective des canaux potassiques kv1.3
WO2007066115A3 (fr) Agents d'imagerie innovants pour la fibrose
DE60204336D1 (de) Atemfunktionsanalyse mittels kapnographie
NO20083104L (no) Fast preparat
IL202487A (en) Annals of 5,5 '- (hydroxyalkyl-diethyl) bis (formylazandyl) bis (2,4,6-triiodophenyl preserved), a diagnostic factor containing them and methods of diagnosis and imaging containing these factors
WO2007103373A3 (fr) Compositions et procédés pour le traitement de troubles immunoinflammatoires
Tangerman et al. Halitosis and Helicobacter pylori infection
SG170823A1 (en) Test agent for diagnosing dyspepsia
WO2006059252A3 (fr) Procedes et compositions fluorees pour le traitement de maladies associees aux amyloides
NO20092248L (no) Ny forbindelse med affinitet for amyloid
WO2006138372A3 (fr) Procedes et reactifs pour le traitement de troubles inflammatoires
MX2009005855A (es) Formulaciones inhalables de bisfosfonato enlazado con polimero y metodos de uso de las mismas.
UY30797A1 (es) Un método mediante una prueba de aliento para la deteccion de microorganismos patogenos
WO2008027533A3 (fr) Compositions pour soins personnels comprenant un extrait de pépins de poire
Radon et al. Lack of combined effects of exposure and smoking on respiratory health in aluminium potroom workers.
WO2008144931A8 (fr) Compositions et procédés pour la modulation des canaux ioniques
EP1707219A3 (fr) Compositions radioactives pour la mesure de l'evacuation gastrique
WO2006099569A3 (fr) Methodes et compositions destinees a traiter la maladie induite par le beryllium
US6626844B1 (en) Method and composition for inhibition of nitric oxide production in the oral cavity